Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DVX18N
|
|||
| Drug Name |
PP-007
|
|||
| Drug Type |
Peptide
|
|||
| Indication | Ischemic stroke [ICD-11: 8B11.5Z; ICD-9: 434.91] | Phase 1 | [1] | |
| Company |
Prolong Pharmaceuticals South Plainfield, NJ
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | TAR DNA binding protein 43 (TARDBP) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04677777) A Randomized, Phase 1, Contemporaneously Controlled, Multicenter Study to Assess the Safety of PP-007 in Subjects With Acute Ischemic Stroke. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.